Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

NCT03454035 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Tumor, Solid
Pancreatic Cancer
Melanoma

Interventions

DRUG: Ulixertinib
DRUG: Palbociclib

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]